Industry News
Opthea Announces Leadership Changes as it Prepares for Phase 3 Data on Sozinibercept

Opthea has announced key leadership appointments to strengthen its commercial and clinical capabilit...

read more
Opthea Announces Leadership Changes as it Prepares for Phase 3 Data on Sozinibercept
September 06, 2924
BlueRock Therapeutics Receives FDA Clearance for OpCT-001 IND Application

BlueRock Therapeutics, a subsidiary of Bayer, announced that the FDA has cleared its investigational...

read more
BlueRock Therapeutics Receives FDA Clearance for OpCT-001 IND Application
September 05, 2924
New Drug Shows Promise in Protecting Vision in Dry AMD

A new investigational drug, ANX007, offers hope for the millions of people suffering from geographic...

read more
New Drug Shows Promise in Protecting Vision in Dry AMD
October 22, 2024
Long-Term Antiviral Use Key to Treating Ocular Shingles, Research Shows

A new study led by researchers from the Perelman School of Medicine at the University of Pennsylvani...

read more
Long-Term Antiviral Use Key to Treating Ocular Shingles, Research Shows
October 22, 2024
AAO 2024: Several Imaging Modalities Effective in Geographic Atrophy Diagnosis

At the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discus...

read more
AAO 2024: Several Imaging Modalities Effective in Geographic Atrophy Diagnosis
October 21, 2024
AAO 2024: LiGHT Trial Reveals SLT Outperforms Medications in Reducing Glaucoma Progression Over 6 Years

A recent retrospective analysis of the trial data demonstrated that SLT as a first-line treatment si...

read more
AAO 2024: LiGHT Trial Reveals SLT Outperforms Medications in Reducing Glaucoma Progression Over 6 Years
October 21, 2024
AAO 2024: Study Links Dry Eye to Increased Risk of Psychiatric Disorders and Chronic Pain Syndromes

A new study presented at the 2024 American Academy of Ophthalmology (AAO) annual meeting reveals tha...

read more
AAO 2024: Study Links Dry Eye to Increased Risk of Psychiatric Disorders and Chronic Pain Syndromes
October 18, 2024
Google Licenses Diabetic Retinopathy AI for Free Screenings in India and Thailand

Google recently announced the licensing of its diabetic retinopathy AI model to healthcare providers...

read more
Google Licenses Diabetic Retinopathy AI for Free Screenings in India and Thailand
October 18, 2024
New Drug Targets Identified for Treating Inherited Retinal Degenerations

An international team of researchers has discovered new drug targets for inherited retinal diseases,...

read more
New Drug Targets Identified for Treating Inherited Retinal Degenerations
October 17, 2024
After OSA 2024: “Winners Underline the Importance of Recognizing Outstanding Innovations”

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, handed the prestigiou...

read more
After OSA 2024: “Winners Underline the Importance of Recognizing Outstanding Innovations”
October 16, 2024
More